Prabhakar D. Lotlikar

1.7k total citations
78 papers, 1.4k citations indexed

About

Prabhakar D. Lotlikar is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Prabhakar D. Lotlikar has authored 78 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 22 papers in Pharmacology and 22 papers in Cancer Research. Recurrent topics in Prabhakar D. Lotlikar's work include Glutathione Transferases and Polymorphisms (25 papers), Genomics, phytochemicals, and oxidative stress (23 papers) and Pharmacogenetics and Drug Metabolism (21 papers). Prabhakar D. Lotlikar is often cited by papers focused on Glutathione Transferases and Polymorphisms (25 papers), Genomics, phytochemicals, and oxidative stress (23 papers) and Pharmacogenetics and Drug Metabolism (21 papers). Prabhakar D. Lotlikar collaborates with scholars based in United States, Japan and China. Prabhakar D. Lotlikar's co-authors include Elizabeth C. Miller, James A. Miller, Hanumantharao G. Raj, Alfredo Margreth, Peter Magee, Makoto Enomoto, John D. Scribner, Guozhong Qin, E. C. Miller and Yaoyu Ning and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, PLANT PHYSIOLOGY and Cancer Research.

In The Last Decade

Prabhakar D. Lotlikar

78 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Prabhakar D. Lotlikar United States 21 799 461 351 277 214 78 1.4k
Wattenberg Lw United States 9 529 0.7× 263 0.6× 331 0.9× 124 0.4× 104 0.5× 10 1.1k
Mary F. Argus United States 21 668 0.8× 466 1.0× 255 0.7× 120 0.4× 245 1.1× 86 1.6k
Charles C. Irving United States 23 925 1.2× 578 1.3× 198 0.6× 102 0.4× 235 1.1× 68 1.6k
Hira L. Gurtoo United States 28 818 1.0× 863 1.9× 674 1.9× 494 1.8× 175 0.8× 83 2.1k
Charlotte Witmer United States 19 515 0.6× 521 1.1× 402 1.1× 115 0.4× 157 0.7× 41 1.5k
E. C. Miller United States 18 701 0.9× 438 1.0× 575 1.6× 100 0.4× 230 1.1× 38 1.8k
Joan Booth United Kingdom 19 718 0.9× 240 0.5× 363 1.0× 112 0.4× 261 1.2× 27 1.4k
Kostas P. Vatsis United States 17 777 1.0× 356 0.8× 504 1.4× 94 0.3× 156 0.7× 29 1.5k
Mark A. Morse United States 28 2.0k 2.5× 434 0.9× 319 0.9× 531 1.9× 200 0.9× 74 2.9k
Masakazu Isobe Japan 22 597 0.7× 286 0.6× 224 0.6× 144 0.5× 145 0.7× 64 1.3k

Countries citing papers authored by Prabhakar D. Lotlikar

Since Specialization
Citations

This map shows the geographic impact of Prabhakar D. Lotlikar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Prabhakar D. Lotlikar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Prabhakar D. Lotlikar more than expected).

Fields of papers citing papers by Prabhakar D. Lotlikar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Prabhakar D. Lotlikar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Prabhakar D. Lotlikar. The network helps show where Prabhakar D. Lotlikar may publish in the future.

Co-authorship network of co-authors of Prabhakar D. Lotlikar

This figure shows the co-authorship network connecting the top 25 collaborators of Prabhakar D. Lotlikar. A scholar is included among the top collaborators of Prabhakar D. Lotlikar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Prabhakar D. Lotlikar. Prabhakar D. Lotlikar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qin, Guozhong, Yaoyu Ning, & Prabhakar D. Lotlikar. (2000). Chemoprevention of Aflatoxin B1-Initiated and Carbon Tetrachloride-Promoted Hepatocarcinogenesis in the Rat by Green Tea. Nutrition and Cancer. 38(2). 215–222. 21 indexed citations
2.
Su, Jianjia, et al.. (1997). Expression of p53 gene in hepatocellular carcinomas induced by aflatoxin B1 with or without human hepatitis B virus in tree shrews. Experimental & Molecular Medicine. 29(3). 177–182. 3 indexed citations
3.
Qin, Guozhong, et al.. (1997). p53 protein expression in patients with hepatocellular carcinoma from the high incidence area of Guangxi, Southern China. Cancer Letters. 121(2). 203–210. 10 indexed citations
4.
Hiruma, Shingo, et al.. (1996). Effect of cell proliferation on initiation of aflatoxin B1-induced enzyme altered hepatic foci in rats and hamsters. Carcinogenesis. 17(11). 2495–2499. 15 indexed citations
5.
6.
Jensen, David E., et al.. (1992). Glutathione conjugation of microsome-mediated and synthetic aflatoxin B1-8,9-oxide by purified glutathione S-transferases from rats. Cancer Letters. 64(3). 225–233. 34 indexed citations
7.
Horiuchi, Atsushi, et al.. (1991). Effects of partial hepatectomy, phenobarbital and buthionine sulfoximine on rat hepatocytes positive for the placental form of aflatoxin B_1-induced glutathione transferase. 16(2). 155–163. 3 indexed citations
8.
Lotlikar, Prabhakar D., et al.. (1991). Aflatoxin B1-DNA binding and aflatoxin B1-glutathione conjugation with isolated hepatocytes from rats and hamsters.. PubMed. 427–30. 3 indexed citations
9.
Lotlikar, Prabhakar D.. (1989). Metabolic Basis for Susceptibility and Resistance to Aflatoxin B1Hepatocarcinogenesis in Rodents. Journal of Toxicology Toxin Reviews. 8(1-2). 97–109. 11 indexed citations
10.
Trézl, L., et al.. (1988). Studies on reaction of formaldehyde with naturally occurring thiol compounds and ascorbic acid. Archives of Pharmacal Research. 11(2). 114–121. 4 indexed citations
11.
Raj, Hanumantharao G. & Prabhakar D. Lotlikar. (1984). Urinary excretion of thiol conjugates of aflatoxin B1 in rats and hamsters. Cancer Letters. 22(2). 125–133. 20 indexed citations
12.
13.
Lotlikar, Prabhakar D., et al.. (1982). Ring- and N-hydroxylation of 2-acetylaminofluorene by reconstituted mouse liver microsomal cytochrome P-450 enzyme system. Toxicology Letters. 11(1-2). 173–179. 2 indexed citations
14.
Lotlikar, Prabhakar D., et al.. (1971). Acetylation of the Carcinogen N-Hydroxy-2-acetylaminofluorene by Acetyl Coenzyme A to Form a Reactive Ester. Molecular Pharmacology. 7(4). 381–388. 12 indexed citations
15.
Lotlikar, Prabhakar D. & Margot Gruenstein. (1970). Effects of adrenalectomy and bile-duct ligation on the urinary excretion of metabolites of 2-acetamidofluorene by male weanling rats. Biochemical Journal. 119(5). 921–923. 2 indexed citations
16.
Lotlikar, Prabhakar D.. (1968). Enzymatic N-O-methylation of hydroxamic acids. Biochimica et Biophysica Acta (BBA) - General Subjects. 170(2). 468–471. 6 indexed citations
17.
Lotlikar, Prabhakar D., Elizabeth C. Miller, James A. Miller, & Alfredo Margreth. (1965). The enzymatic reduction of the N-hydroxy derivatives of 2-acetylaminofluorene and related carcinogens by tissue preparations.. PubMed. 25(10). 1743–52. 134 indexed citations
18.
Margreth, Alfredo, Prabhakar D. Lotlikar, Elizabeth C. Miller, & James A. Miller. (1964). THE EFFECTS OF HEPATOTOXIC AGENTS AND OF LIVER GROWTH ON THE URINARY EXCRETION OF THE N-HYDROXY METABOLITE OF 2-ACETYLAMINOFLUORENE BY RATS.. PubMed. 24. 920–5. 11 indexed citations
19.
Lotlikar, Prabhakar D., Makoto Enomoto, Elizabeth C. Miller, & James A. Miller. (1964). THE EFFECTS OF ADRENALECTOMY, HYPOPHYSECTOMY, AND CASTRATION ON THE URINARY METABOLITES OF 2-ACETYLAMINOFLUORENE IN THE RAT.. PubMed. 24. 1835–44. 20 indexed citations
20.
Enomoto, Makoto, Prabhakar D. Lotlikar, James A. Miller, & Elizabeth C. Miller. (1962). Urinary Metabolites of 2-Acetylaminofluorene and Related Compounds in the Rhesus Monkey. Cancer Research. 22. 1336–1342. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wattenberg Lw Breakdown of academic impact, for papers by Mary F. Argus Breakdown of academic impact, for papers by Charles C. Irving Breakdown of academic impact, for papers by Hira L. Gurtoo Breakdown of academic impact, for papers by Charlotte Witmer Breakdown of academic impact, for papers by E. C. Miller Breakdown of academic impact, for papers by Joan Booth Breakdown of academic impact, for papers by Kostas P. Vatsis Breakdown of academic impact, for papers by Mark A. Morse Breakdown of academic impact, for papers by Masakazu Isobe
Rankless by CCL
2026